IMO, the market will eventually shift to the healthcare sector again in the near future - when it happens, NVO will see a significant price change upward.
In addition, since mid-August, there has been a nice buying volume in the 53ish-55ish zone.
The real question is whether you are a long-term investor with patience or a trader.
Risk-Reward perspective:
Let's assume one opens a position and buys a bunch of shares at $50 average price.
What's the worst case? NVO reaches $0 - not gonna happen, but we are taking it into account.
What's the average case? Getting back to $70ish - $80ish zone - can be easily achieved within 1-2 weeks once the MM start pouring money back into the healthcare sector.
Now, what's the best case? Getting back to the $140ish zone - absolutely in the cards but may take a while.
The position with $50 average price can easily double itself. It's just a matter of time.
It is a perfect risk-reward case, especially with a company as big and profitable as NVO.
We have to remember that when the absurd hype of the $0-profitable companies (like NNE, OKLO etc.) comes to an end, the real profitable companies will start seeing money back.
As for me personally, I don't mind if it heads back to $45ish, which provides an excellent opportunity to load more shares/ calls.